Representing

E - bonitete

Emona Biopharma d.o.o.

Company: Emona Biopharma d.o.o.
Address: Dunajska cesta 177, 1000 LJUBLJANA

Google maps
Municipality: Ljubljana
Region: Central Slovenia (Osrednjeslovenska)
Contacts: 00386 59039150

http://emonabio.com
Egor Gorshkov
 
Company management: Director: Egor Gorshkov
Director: Amit Godbole
Extract of management responsible for a company's business operations abroad: Egor Gorshkov,
Registration number: 6394680
Tax number: 10941681
Organisational form: Limited Liability Company
Source of capital: Mixed
Size of company: Micro
Exports share in income: 56,00 %
Tradition since: 2018
Extract of target regions and countries where a company exports: Croatia
Greece
Ireland
Portugal
Romania
United Kingdom
Desired regions and countries of cooperations: Austria, Canada, Finland, Germany, Italy, Japan, Mexico, Netherlands, Norway, Sweden, United States
Description of company: Emona Biopharma, a GMP certified company based in Ljubljana that specialises in the developing and out-licensing of generics to the European (EU) markets. Emona Biopharma offers a diverse range of pharmaceuticals: solid forms OTCs and Rx, as well as a number of hospital injectables. Our product pipeline keeps on growing.
Our international team have experienced first hand the evolution of the generic licensing landscape in Europe, and believe that our focus on supply competitiveness, speed and efficiency of service makes us a viable partner to companies that seek to grow their portfolio through in-licensing cooperation.
Description of products and services: We develop, out-license and supply generic pharmaceuticals in Europe.
Following is a list of eCTD dossiers that are available for registration or are still in the development pipeline. We operate primarily in the markets of Europe and our products fully comply with EU requirements.

AVAILABLE:
- Folic acid, 5mg tablets
- Betahistine 8mg, 16mg, 24mg tablets
- Midazolam, 5mg/1ml and 15mg/3ml ampoules
- Atomoxetine capsules
- Mirtazapine tablets
- Cyanocobalamine injection

PRODUCT PIPELINE:
- Bisacodyl, 5 mg tablets
- Amikacin, 500 mg / 2 ml vials
- Pantoprazole, 40 mg lyophilized powder for injection
- Adrenaline, 1 mg / ml ampoules
Classification of company:
Main activity in accordance with the NACE classification
21.200 Manufacture of pharmaceutical preparations
Activities in accordance with the CPA classification
21.20.99 Sub-contracted operations as part of manufacturing of pharmaceutical preparations
Field of activity: Pharmaceutical and Biotechnology
Information on the presentation card companies are obtained from surveys. Financial data are for the financial year 2022, last update 30.06.2023.
Last data update 20.03.2024.